AI Debt Is Flowing Into Insurance Assets Regulators Cannot Track, Forbes Analysis Finds

Insurers are absorbing AI-linked debt they cannot fully measure while simultaneously excluding AI risk from the corporate liability coverage they sell. A Forbes investigation published October 8 describes this dual exposure as a systemic blind spot that regulators are only beginning to acknowledge — and one that has no clear resolution in current oversight frameworks.

The problem isn't that AI is involved in insurance. It's that financial instruments tied to AI infrastructure buildout are accumulating inside insurance investment portfolios in forms that existing regulatory classification systems were not designed to recognize.

Two Sides of the Same Problem

The Forbes analysis identifies an unusual asymmetry in how the insurance industry is positioned relative to AI risk — exposure on both sides of the balance sheet moving in opposite directions.

The liability side: AI is being written out.

Insurers are carving AI-related incidents out of corporate liability coverage at an accelerating pace. When an AI system causes harm — a biased hiring algorithm that excludes qualified candidates, an autonomous vehicle system that causes an accident, a clinical AI tool that contributes to a misdiagnosis — the insurer's position is increasingly that this falls outside standard policy terms. AI incidents are being treated as a new category of risk too unpredictable to price, and corporate buyers are discovering coverage gaps when they file claims.

The investment side: AI debt is being absorbed.

In their investment portfolios, the same insurers are accumulating AI-linked debt instruments — bonds, structured credit facilities, and financing arrangements tied to the AI infrastructure buildout: data center construction, GPU procurement, AI model training facilities, and the broader capital stack of AI-intensive companies. These instruments often don't have a standard classification under existing regulatory frameworks, which were designed for physical assets and conventional financial products.

The result: the same organization is writing AI risk out of its liability book while absorbing AI-linked credit exposure in its investment book — without accurate tools to quantify either position.

Why the Regulatory Frameworks Don't Fit

Insurance investment portfolios are regulated through capital adequacy frameworks — rules that require insurers to hold reserves proportional to the risk profile of their assets. These frameworks depend on asset classification systems built before AI debt instruments existed as a distinct category.

Bonds tied to hyperscale AI data center construction, structured credit facilities financing GPU procurement at scale, and financing arrangements for AI infrastructure companies don't have standardized risk classifications. Regulators can see that insurers are holding these assets. What they can't yet do is assess the risk profile accurately — particularly for the scenario in which AI infrastructure buildout slows, reprices, or defaults in correlated patterns across the sector.

The correlation risk is the understated dimension here. A broad repricing of AI infrastructure debt — if AI investment enthusiasm cools, if a major model developer's revenue fails to match its capital costs, or if data center overbuilding produces a glut — would affect insurers across the sector simultaneously. That's the definition of systemic risk: correlated exposure that affects the backstop simultaneously, not individual institutions independently.

What Corporate Buyers Are Facing Now

For companies deploying AI systems, the insurance gap is already a practical problem. Legal and risk managers at organizations using AI across customer service, hiring, healthcare, financial advice, and autonomous operations are finding that policies they purchased assuming AI coverage are explicitly excluding it in new policy cycles.

The mismatch creates a governance problem. Corporate boards are being asked to approve AI deployments while risk transfer mechanisms — insurance — are simultaneously narrowing. The risk isn't disappearing; it's being retained by the enterprise deploying the AI rather than transferred to an insurer. That changes the calculus for AI deployment decisions in risk-conscious organizations like banks, hospitals, and regulated utilities.

What Regulators Are Doing — and Not Doing

The National Association of Insurance Commissioners (NAIC) and the International Association of Insurance Supervisors (IAIS) are both working on AI-related insurance policy frameworks. Neither has produced guidance that specifically addresses the classification of AI debt instruments in investment portfolios.

The gap between the pace of AI capital markets activity and regulatory adaptation is the core problem. AI infrastructure financing is being structured, rated, and placed into insurance portfolios on a timeline that outpaces the capacity of regulatory bodies to develop appropriate frameworks.

State insurance commissioners — who set capital adequacy requirements in the US — are the most likely source of initial action. If any major state jurisdiction introduces even a preliminary AI debt instrument classification, it will force insurers to explicitly quantify and disclose their AI-linked credit exposure. That disclosure requirement alone would begin to reveal the scale of the blind spot.

What to Watch

NAIC's AI working group has been meeting regularly throughout 2026. Their next guidance release is the clearest near-term signal. International coordination through IAIS will determine whether AI debt classification becomes a consistent global requirement or fragments across jurisdictions — creating regulatory arbitrage opportunities that sophisticated insurers will exploit.